Prognostic risk stratification value of MACC1 expression in patients with gastric cancer
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03550-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Xia Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Taizhou Hospital of Zhejiang P…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Transcription Factors, Biomarkers, Tumor. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Science and Technology Program of Zhejiang Province, Taizhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
BACKGROUND: The prognostic significance of metastasis-associated in colon cancer-1 (MACC1) has been explored in a variety of malignancies. However, its clinical relevance in patients with gastric cancer (GC) is limited, also remains controversial. METHOD: In this study, we retrospectively evaluated the prognostic value of lesion MACC1 expression in 347 GC patients. Lesion MACC1 expression was analyzed with immunohistochemistry and grouped as MACC1low (n = 172) and MACC1high (n = 175) cases. RESULTS: Data revealed that the degree of MACC1 expression is not related to patient sex, age and disease stage (all p > 0.05). Survival analysis showed that only post-operation advanced pT (p = 0.018), pN (p < 0.001), pM (p = 0.001) and AJCC stages (p < 0.001) are significantly associated with shorter survival, while no obvious difference was observed between MACC1low and MACC1high cases (p = 0.158). However, we found that survival for female (p = 0.032), older (p = 0.028), and early disease stage (pT stage I + II, p = 0.033) patients with MACC1high are remarkably worse than those with MACC1low. CONCLUSION: In summary, our findings revealed that, though MACC1 expression is not associated with the survival of the whole cohort, the prognostic risk stratification value of lesion MACC1 expression in subgroups of patients with gastric cancer should be noted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Minimally Invasive Techniques & Rapid Rehabilitation of Digestive System Tumor of Zhejiang Province, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of Chin…
- Biological Resource Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China.
- Department of Medical Service, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, 317000, People's Republic of China.
- Medical Research Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, Zhejiang, 317000, People's Republic of China. yanwh@enzemed.com.
- Biological Resource Center, Taizhou Hospital of Zhejiang Province, Wenzhou Medical University, Linhai, People's Republic of China. linaf@enzemed.com.
Förderung
- Science and Technology Program of Zhejiang Province
- Taizhou Municipal Science and Technology Bureau
Zitieren
APA
Zhang, X., Feng, X. J., Han, Q. Y., Zhang, J. G., Yan, W. H., & Lin, A. (2024). Prognostic risk stratification value of MACC1 expression in patients with gastric cancer. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03550-0
Vancouver
Zhang X, Feng XJ, Han QY, Zhang JG, Yan WH, Lin A. Prognostic risk stratification value of MACC1 expression in patients with gastric cancer. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03550-0
BibTeX
@article{Zhang2024,
author = {Zhang, Xia and Feng, Xing-Jun and Han, Qiu-Yue and Zhang, Jian-Gang and Yan, Wei-Hua and Lin, Aifen},
title = {Prognostic risk stratification value of MACC1 expression in patients with gastric cancer},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03550-0}
}
EUVIMED